| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.7001 | 47 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.0476 | 32 |
| GSM780709 | Untreated after 4 days (C3_1) | 49.4697 | 47 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.1009 | 52 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.1709 | 28 |
| GSM780721 | Untreated after 4 days (C3_2) | 53.2383 | 57 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.3814 | 15 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.6693 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 49.6727 | 47 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.9691 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.9032 | 27 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.5589 | 30 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.7461 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.3206 | 19 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.1228 | 49 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.3501 | 29 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.6312 | 47 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.5734 | 25 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.5444 | 11 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.6816 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.6475 | 25 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.6662 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.9371 | 36 |